About ISCBI
The ISCBI membership includes more than 200 stem cell scientists and other experts from stem cell banks, stem cell societies, academia, industry and regulatory bodies, from 23 countries. It is managed by the ISCBI Executive Board.
ISCBI has a Steering Group which advises the ISCBI Executive Board and drives the organisation of annual meetings and workshops. The international Steering Group is comprised of leading experts in stem cell banking and its membership was most recently updated in November 2020 (see below).
The ISCBI is an open community and welcomes new-comers interested in establishing and developing stem cell resources for local, national and international use.
ETHOS
The guiding principles for the development of ISCBI have been
-
Diversity:
-
To bring together stem cell biobanks supporting diverse applications
-
To engage diverse expertise and knowledge: stem cell biobanks, leading stem cell research groups, scientific societies, regulators, industry, funders and policy groups
-
-
Inclusivity:
-
Promoting equal access to meetings to all stakeholders and countries
-
Assuring that every country has a voice.
-
ISCBI Executive Board
Glyn Stacey
Institute of Zoology, Chinese academy of Sciences, Beijing, China
Rosario Isasi
University of Miami, USA
Andreas Kurtz
Fraunhofer-IBMT
Universitatzmedizine Berlin, Germany
ISCBI Steering Group
Elsa Abranches
UK Stem Cell Bank, NIBSC-MHRA, UK
Jeremy Crook
Australian Institute of Innovative Materials (AIIM), University of Wollongong, Australia.
Mathilde Girard
I-Stem/Yposkesi, Paris, France
Maneesha Inamdar
JNCASR, Bangalore, India
Jung-Hyun Kim
KNIH, Osong, Korea
Eihachiro Kawase
Institute for Frontier Life and Medical Sciences, Kyoto University, Japan
Tennielle Ludwig
WiCell, Madison, USA
Julia Neubauer
Fraunhofer-IBMT/EBiSC, Sarbrukken, Germany
Steve Oh
Bioprocessing Technology Institute
20 Biopolis Way, #06-01 Centros,
SINGAPORE 138668
Minal Patel
Wellcome Trust/Sanger Institute, HipSci, Cambridge, UK
Michael Peitz
Institute of Reconstructive Neurobiology
LIFE & BRAIN Center
University Hospital of Bonn
Germany
Martin Pera
Jackson Laboratories/ISCI, Barharbor, USA
Marc Peschanski
I-Stem Institute, Paris, France
Michael Sheldon
RUCDR, USA
Stephen Sullivan
GAiT, UK
Patricia Pranke
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Fanyi Zeng
Shanghai Jiao Tong University, China
Qi Zhou
Institute of Zoology, Chinese academy of Sciences, Beijing, China
Terms of Reference:
The Advisory Board works to promote best practice and high quality training opportunities in the use of pluripotent stem cell lines.
ISCBI Team Support
Jenny Nelder
J.N. Admin & Events
ISCBI Administrator & Events Organiser
